M2Gen

14 articles with M2Gen

• 

  Biopharma Executive Perspectives on 2022

  1/10/2022

  BioSpace sat down with 12 executives who shared their thoughts on the coming year and decade.

• M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology

  12/9/2021

  M2GEN will utilize Microsoft technologies to power its data and analytics platform.

• M2GEN-supported research network ORIEN® begins COVID-19 study in cancer patients funded through the ORIEN Foundation

  10/1/2020

  The Oncology Research Information Exchange Network (ORIEN), an alliance of 18 of the top national cancer centers, announced today the initiation of a COVID-19 study in cancer patients funded through the ORIEN Foundation. ORIEN members have the unique potential to contribute significantly to understanding not only the short-term effects

• M2GEN and Discovery Life Sciences Enter into Agreement to Leverage M2GEN's New Oncology-Focused Bioinformatics Support Services

  9/25/2020

    M2GEN  announced today that it has entered into an agreement with Discovery Life Sciences, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, to provide M2GEN's recently launched oncology-focused bioinformatics support services.

• M2GEN® Appoints Chris Tunnell Vice President of Global Sales

  5/7/2020

  M2GEN, an oncology-focused health informatics solutions company with the mission to help patients access the best treatment options by leveraging their clinical and molecular data to accelerate the discovery, development and delivery of tailored and more personalized therapies, announced today the appointment of Chris Tunnell as Vice Pres

• 

  BioSpace Movers & Shakers, Aug. 16

  8/16/2019

  Biopharma companies strengthen their executive ranks and boards with new additions.

• M2Gen® Appoints Dr. Helge Bastian President and Chief Executive Officer

  8/14/2019

  Bastian succeeds M2Gen Executive Chair William S. Dalton, M.D., Ph.D., who has served as interim CEO since September 2018.

• M2Gen Announces BMS' Participation in ORIEN Avatar Research Program

  10/27/2017

  M2Gen announced today that Bristol-Myers Squibb has joined the Oncology Research Information Exchange Network Avatar Research Program.

• Hearst Invests In H. Lee Moffitt Cancer Center & Research Institute Subsidiary M2Gen

  9/20/2017

• AbbVie And M2Gen Announce New Collaboration For The Oncology Research Information Exchange Network (ORIEN) Avatar Research Program

  3/28/2017

• M2Gen Announces That Merck & Co. Joins The Oncology Research Information Exchange Network (ORIEN) Avatar Research Program

  1/5/2017

• M2Gen Selects DNAnexus To Manage Molecular Data For ORIEN Avatar Research Program

  9/22/2016

• Takeda And M2Gen Collaborate With ORIEN To Speed Clinical Development And Discovery Of Cancer Treatments Through Health Informatics

  6/16/2016

• M2Gen Release: Leading Cancer Centers And Biopharmaceutical Companies Launch Unprecedented Alliance To Advance Development Of Precision Medicines For Cancer Patients

  4/7/2016